DAZL
Deleted in azoospermia-like
Also known as: DAZH, DAZL_HUMAN, DAZL1, DAZLA, MGC26406, SPGYLA
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q92904
- Gene
- DAZL
- Ensembl
- ENSG00000092345
- Chromosome
- 3
- Canonical length
- 295 aa
- Protein class
- Predicted intracellular proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The DAZ (Deleted in AZoospermia) gene family encodes potential RNA binding proteins that are expressed in prenatal and postnatal germ cells of males and females. The protein encoded by this gene is localized to the nucleus and cytoplasm of fetal germ cells and to the cytoplasm of developing oocytes. In the testis, this protein is localized to the nucleus of spermatogonia but relocates to the cytoplasm during meiosis where it persists in spermatids and spermatozoa. Transposition and amplification of this autosomal gene during primate evolution gave rise to the DAZ gene cluster on the Y chromosome. Mutations in this gene have been linked to severe spermatogenic failure and infertility in males. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2010]
Canonical amino-acid sequenceUniProt
295 residues, UniProt reviewed canonical sequence.
>Q92904|DAZL
1 MSTANPETPN STISREASTQ SSSAATSQGY ILPEGKIMPN TVFVGGIDVR MDETEIRSFF
61 ARYGSVKEVK IITDRTGVSK GYGFVSFFND VDVQKIVESQ INFHGKKLKL GPAIRKQNLC
121 AYHVQPRPLV FNHPPPPQFQ NVWTNPNTET YMQPTTTMNP ITQYVQAYPT YPNSPVQVIT
181 GYQLPVYNYQ MPPQWPVGEQ RSYVVPPAYS AVNYHCNEVD PGAEVVPNEC SVHEATPPSG
241 NGPQKKSVDR SIQTVVSCLF NPENRLRNSV VTQDDYFKDK RVHHFRRSRA MLKSVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DAZL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.59
- Highest tissue expression
- 75 nTPM
Expression across tissuesHPA
Tissue
- testis: 75 nTPM
- tonsil: 0.9 nTPM
- appendix: 0.3 nTPM
- lymph node: 0.3 nTPM
- ovary: 0.3 nTPM
- stomach: 0.3 nTPM
Single-cell type
- early primary spermatocytes: 307 nCPM
- differentiating spermatogonia: 150 nCPM
- late primary spermatocytes: 145 nCPM
- late spermatids: 57 nCPM
- undifferentiated spermatogonia: 54 nCPM
- early spermatids: 50 nCPM
Immune cell
- naive B-cell: 0.4 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebral cortex: 0.2 nTPM
- hypothalamus: 0.2 nTPM
- midbrain: 0.1 nTPM
- thalamus: 0.1 nTPM
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about DAZL.
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 47 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Idiopathic male infertility
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.24
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 0.44
- DepMap mean gene effect
- -0.14
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- 3'-UTR-mediated mRNA stabilization
- female meiosis II
- germ cell development
- oocyte maturation
- positive regulation of meiotic nuclear division
- positive regulation of translational initiation
- spermatogenesis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DAZL in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DAZL as an antibody target. Whether an autoantibody or antibody against DAZL could matter depends on whether native DAZL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DAZL is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DAZL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...